neostigmine has been researched along with methylnaltrexone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Delaney, CP; Stulberg, JJ; Zeinali, F | 1 |
| Baker, JN; Coleman, JL; Johnson, LM; Spraker, HL | 1 |
1 review(s) available for neostigmine and methylnaltrexone
| Article | Year |
|---|---|
Pharmacological management of postoperative ileus.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Bisacodyl; Cathartics; Cisapride; Dihydroergotamine; Humans; Ileus; Inflammation; Naltrexone; Neostigmine; Parasympathomimetics; Piperidines; Postoperative Complications; Propranolol; Quaternary Ammonium Compounds; Receptors, Opioid, mu; Serotonin Receptor Agonists | 2009 |
1 other study(ies) available for neostigmine and methylnaltrexone
| Article | Year |
|---|---|
An unusual case of Ogilvie syndrome in a pediatric oncology patient receiving palliative care after failed treatment with neostigmine.
Topics: Adolescent; Cholinesterase Inhibitors; Colonic Pseudo-Obstruction; Colonoscopy; Diagnosis, Differential; Fatal Outcome; Female; Humans; Ileostomy; Naltrexone; Narcotic Antagonists; Neostigmine; Osteosarcoma; Palliative Care; Quaternary Ammonium Compounds; Sarcoma, Small Cell; Treatment Failure | 2012 |